FDA Fully Approves Pfizer-BioNTech Covid-19 Vaccine
On Monday, the Food and Drug Administration fully approved the Pfizer-BioNTech Covid-19 vaccine for the prevention of Covid-19 in people 16 or older. The vaccine will be marketed under the name Comirnaty.
Said Acting FDA Commissioner Janet Woodcock, M.D., "The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic...the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product."
The vaccine will continue to be available under emergency use authorization for individuals that are 12 to 15 years of age.
The FDA approval will also potentially make it easier for schools and employers to require vaccinations.
Photo Source: commons.wikimedia.org